TD Cowen notes Vyvgart’s $790M in Q1 net sales beat consensus and firm’s estimate despite expected, typical Q1 seasonality and unexpected and more pronounced Part D redesign headwinds. Management are confident sales will continue their solid growth in Q2 as “volume growth was robust in Q1 and misunderstood by investors,” according to the analyst, who views the selloff as a buying opportunity given the “robust trends.” The firm keeps a Buy rating and $761 price target on Argenx (ARGX) shares.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Argenx price target lowered to $1,065 from $1,100 at Guggenheim
- Buy Recommendation for Argenx: Strong Vyvgart Sales Growth and Promising PFS Launch Drive Confidence
- Argenx price target raised to $803 from $796 at Citi
- Argenx Reports Strong Q1 2025 Financial Performance
- Argenx Se: Strong Sales and Financial Performance Reinforce Buy Rating Amid Stock Selloff